Skip to main content
DXC logo

DXC · DXC Technology Co

Track DXC — free
$14.37 +0.11 (+0.77%)
Market Cap
$2.22B
Shares
155.47M
Volume · Nov 18 373.95K Avg daily vol (3M) 3.64M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$14.26 Open$14.41 Day$13.83–14.52 52W close$8.22–16.30 Avg vol 30d4.7M Short int20.3M · 13.0% of shares · 3.4d Short vol75% Last earningsOct 29, 2026 DataJan 2020–Nov 2026 Filing10-Q · Oct 30

Up next

Jan 28, 2027 Est · unconfirmed · in 10 wks

Latest documents

2026
Oct 30
Quarterly report 10-Q FY2027 Q2, ended Sep 30
Organic revenue falls 4.0%; EBIT drops 52.2% to $66 million

DXC's second-quarter fiscal 2027 revenue was $3.0 billion, down 4.0% on an organic basis, while EBIT fell to $66 million, down 52.2%. Adjusted EBIT was $187 million, down 26.4%.

Revenue $3.03B ▼ 4.0% Net income $24M ▼ 33.3% Diluted EPS $0.15 ▼ 25.0%
Read from the MD&A section
2 source passages
For the second quarter of fiscal 2027, our total revenue was $3.0 billion, a decrease of $127 million or 4.0% on an organic basis, compared to the same period a year ago. EBIT was $66 million, down 52.2% with a corresponding margin of 2.2%. Adjusted EBIT was $187 million, down 26.4% with a corresponding margin of 6.2%; Open the document at this passage
Oct 29
Current report 8-K
Revenue falls 4.0%; insurance business sale talks acknowledged

DXC Technology reported second-quarter fiscal 2027 total revenue of $3.03 billion, down 4.0% year-over-year, and non-GAAP diluted EPS of $0.67, down 20.2%. It acknowledged ongoing discussions regarding a possible sale of its insurance business. Full-year fiscal 2027 revenue is guided between $11.91 billion and $11.98 billion.

Financial results
5 source passages
On October 29, 2026, DXC Technology Company (the “Company”) issued a press release reporting its financial results for the second quarter of fiscal 2027 ended September 30, 2026. Total revenue was $3.03 billion, down 4.0% year-over-year (down 4.0% on an organic basis).(1) Non-GAAP diluted earnings per share(3) was $0.67, down 20.2% year-over-year. DXC acknowledges ongoing discussions regarding a possible sale of its insurance business. Total revenue in the range of $11.91 billion and $11.98 billion, a decline of 5.5% to 5.0% year-over-year on an organic basis.(1) Open the document at this passage
Jul 31
Quarterly report 10-Q FY2027 Q1, ended Jun 30
Quarterly report for FY2027 Q1 AI summary on its way
Revenue $3B ▼ 5.1% Net income $122M ▲ 662.5% Diluted EPS $0.73 ▲ 711.1%
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$12.36B
Trailing 12 months
Net income (TTM)
$112.00M
Trailing 12 months
Revenue growth YoY
-4.0%
Year over year
Operating margin
6.8%
Trailing 12 months
P / E (TTM)
20.7
Trailing earnings · reciprocal yield 4.8%
FCF yield
46.5%
TTM · current market cap
Return on invested capital
4.9%
Trailing 12 months
Net cash
−$1.46B
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-9.6%
Year over year · fewer shares
Price change (1Y)
+14.4%
Trailing year
Short interest
13.0%
Latest settlement · 3.4 days to cover
View all 125 metrics

AI Brief

Q4 FY26 earnings call · May 7, 2026
Q4 FY26

TL;DR. DXC delivered Q4 adjusted EBIT margin and full-year free cash flow ahead of expectations, but Q4 organic revenue missed guidance by ~$75M (6.6% organic decline) on weaker project-based services. For FY27, DXC guided to a further 3–5% organic revenue decline with adjusted EBIT margin of 6–7% and FCF of ~$600M, all below FY26.

Bullish
  • + Q4 adjusted EBIT margin of 7.6% was above guidance and up 30 bps YoY
  • + Reduced debt by $808M via cash payments over two years and net debt by $1.1B
  • + FY26 share repurchases of $250M retired nearly 10% of outstanding shares
Bearish
  • − Q4 organic revenue missed guidance by ~$75M, declining 6.6% YoY
  • − FY27 guidance implies further deterioration: 3–5% organic revenue decline and 6–7% adjusted EBIT margin
  • − FY27 free cash flow guided to ~$600M, down from $713M in FY26
  • − FY27 non-GAAP EPS guided to $2.40–$2.90, down from $3.23 in FY26

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Buy Momentum Neutral Sentiment Neutral Fundamentals Weak Quant / Vol Very High
Market backdrop VIX 25.5 · fear Equity put/call 0.71
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +23%
above
Price vs 50-day avg +8%
above
RSI (14) 49
neutral
MACD trend Negative
52-week position 75%
mid-range
Momentum
relative strength
Neutral
1-month return −3%
trailing
6-month return +54%
trailing
YTD return −3%
this year
Relative strength +57%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $13 › 200d $12 — 50d above 200d
Institutional flow Distributing
-3% holders QoQ · +56 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
13.03% of shares out · ▼ -22.9% MoM · 3.4 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
431 holders — near 3-yr low, contrarian setup
Squeeze score 63
elevated · 0–100
Fundamentals
Weak
Revenue growth −2%
Y/Y
EPS growth −95%
Y/Y
Free cash flow $1.0B
Valuation P/E 20.7
in line
Buyback $212.0M
remaining
Balance sheet $1.8B
net debt
Quant / Vol
risk profile
Very High
Volatility 57%
annualized · 1-yr
Max drawdown −47%
past year
ATR 5.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 4 of last 8
Latest guidance · from the 8-K filed Oct 29, 2026
Full Fiscal Year 2027
Total revenue Lowered $11.91B – $11.98B
Jul 30, 2026 $12.1B – $12.35B changed to Oct 29, 2026 $11.91B – $11.98B
prior FY $12.64B midpoint −5.5% Y/Y
Adjusted EBIT margin(2) Non-GAAP Lowered 5.75% – 6.25%
Jul 30, 2026 6% – 7% changed to Oct 29, 2026 5.75% – 6.25%
Non-GAAP diluted EPS(3) Non-GAAP Lowered $2.25 – $2.50
Jul 30, 2026 $2.40 – $2.90 changed to Oct 29, 2026 $2.25 – $2.50
Free Cash Flow(4) Non-GAAP Lowered $600M
Jul 30, 2026 $685M changed to Oct 29, 2026 $600M
Third Quarter Fiscal Year 2027
Total revenue $2.98B
prior qtr $3.03B midpoint −1.8% QoQ
Adjusted EBIT margin(2) Non-GAAP 6%
Non-GAAP Diluted EPS(3) Non-GAAP $0.55
FY27 Guidance
YoY Organic Revenue % Non-GAAP -5.5% – -5%
Non-GAAP Tax Rate Non-GAAP 42%
Q3 FY27 Guidance
YoY Organic Revenue % Non-GAAP -6%
Foreign Exchange Impact on Revenues % -0.8%
Non-GAAP Tax Rate Non-GAAP 44%
Previous outlook earlier release · from the Earnings Call filed Jul 30, 2026

Still-open targets the latest release did not restate under the same label.

Share repurchases · fiscal year 2027 $250M
Bond retirement · fiscal year 2027 (bonds maturing September 2026) $400M
Prior guidance period ended · from the 8-K filed Jul 30, 2026
Adjusted EBIT margin · Second Quarter Fiscal 2027 6%
Non-GAAP Diluted EPS · Second Quarter Fiscal 2027 $0.55
Guided vs delivered · last 8 settled
Total revenue Full Year Fiscal 2026
guided $12.67B – $12.81B
$12.64B Miss −0.8%
Total revenue Third Quarter Fiscal 2026
guided $3.18B – $3.22B
$3.19B In line
Revenue Q2 FY24
guided $3,430 – $3,460
$3.44B Beat +99738651.8%
Revenue FY24
guided $13,880 – $14,030
$13.67B Beat +97936123.6%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy
1 · 3 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+23% Bullish
Price vs 50-day avg
+8% Bullish
RSI (14)
49 Neutral
MACD trend
Negative Bearish
52-week position
75% Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $13 › 200d $12 — 50d above 200d
Institutional flow Distributing
-3% holders QoQ · +56 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
13.03% of shares out · ▼ -22.9% MoM · 3.4 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
431 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $8 Now $14 · 75% Range high $16
vs 200-day avg +23% vs 50-day avg +8%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Cash conversion cycle 14 Three Months Ended June 30, 2026 filing —
Days of purchases outstanding in accounts payable -57 Three Months Ended June 30, 2026 filing —
Days of sales outstanding in accounts receivable 71 Three Months Ended June 30, 2026 filing —
Non-GAAP income before income taxes non-GAAP $138M the three months ended June 30, 2026 filing —
GAAP → non-GAAP reconciliation
GAAP Income before income taxes 241M
+26M RestructuringCosts
+87M Amortizationof AcquiredIntangibleAssets
-214M Gain onLitigation Award
-2M Gains on Dispositions
= Non-GAAP income before income taxes 138M
Organic revenue growth (CES segment) non-GAAP 3% first quarter of fiscal 2027 filing —
Organic revenue growth (GIS segment) non-GAAP 11.1% first quarter of fiscal 2027 filing —
Shares repurchased under our Share Repurchase Program 6,704,651 the first quarter of fiscal 2027 filing —
Total profit for reportable segments 172M the three months ended June 30, 2026 filing —
Adjusted EBIT non-GAAP $150M Q1 FY27 —
Adjusted EBIT margin non-GAAP 5% Q1 FY27 —
Bookings 3B Q1 FY27 —
CES organic revenue growth non-GAAP -3% Three Months Ended June 30, 2026 —
CES profit $100M Three Months Ended June 30, 2026 —
CES profit margin 8.1% Three Months Ended June 30, 2026 —
Free cash flow non-GAAP $314M Q1 FY27 —
GIS organic revenue growth non-GAAP -11.1% Three Months Ended June 30, 2026 —
GIS profit $38M Three Months Ended June 30, 2026 —
GIS profit margin 2.6% Three Months Ended June 30, 2026 —
Insurance organic revenue growth non-GAAP 1.4% Three Months Ended June 30, 2026 —
Insurance profit $34M Three Months Ended June 30, 2026 —
Insurance profit margin 10.7% Three Months Ended June 30, 2026 —
Non-GAAP diluted earnings per share non-GAAP $0.4 Q1 FY27 —
Segment profit margin (Consulting and Engineering Services) 8.1% Q1 FY27 —
Segment profit margin (Global Infrastructure Services) 2.6% Q1 FY27 —
Segment profit margin (Insurance Software & Services) 10.7% Q1 FY27 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Information Technology Services — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
DXC
DXC Technology Co
this stock
$2.22B -2.7% -1.8% 20.7 13.0%
IBM
International Business Machines Corp
$218.41B -22.0% +7.6% 19.7 1.9%
ACN
Accenture plc
$160.08B -10.8% +6.5% 17.7 3.2%
INFY
Infosys Ltd
$48.89B -32.3% — — 2.1%
CTSH
Cognizant Technology Solutions Corp
$26.82B -27.7% +7.0% 10.9 5.2%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
431
% held
106.1%
Net QoQ
-13.8M sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
318
View
Short & Settlement
Short Interest Falling
Shares short
20.3M
Days to cover
3.4d
Change
-6.0M sh
View
Short Volume
Short vol %
75%
As of
Nov 17, 2026
Short Total
View
Fails to Deliver
FTD shares
382.8K
Value
$5.8M
As of
Oct 30, 2026
View
Off-Exchange
Off-exchange %
37.2%
Week of
Oct 12, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Sell
Member
Gilbert Cisneros
Amount
$1.0K–$15.0K
Traded
Apr 29, 2025
View
Financials
Financials
Revenue (FY)
$12.6B
Net income (FY)
$18.0M
EPS diluted
$0.10
View
Buybacks
Authorized
$1.0B
Remaining
$212.0M
Spent Remaining
View
Filings
SEC Filings
Latest
10-Q
Filed
Oct 30, 2026
This year
17

DXC's second-quarter fiscal 2027 revenue was $3.0 billion, down 4.0% on an organic basis, while EBIT fell to $66 million, down 52.2%. Adjusted EBIT was $187 million, down 26.4%.

View
Proposed Sales
Value
$37.9K
Shares
2.5K
Filed
Dec 11, 2025
View
Earnings & Events
Webcasts
Last webcast
Oct 29, 2026
View
Investor Relations
Latest news
City of Charlotte Deploys DXC's N…
Published
Nov 12, 2026
View

Performance

5D 20D 120D MTD YTD
DXC -6.9% -2.5% +53.8% -4.8% -2.7%
SPY -2.3% -4.8% -2.9% -3.1% +7.4%
vs SPY -4.5% +2.2% +56.8% -1.7% -10.1%

Capital returns

Latest dividend
$0.21 / share · ex Mar 24, 2020
Paid (TTM)
$0.00 / share · 0 payouts
Dividend yield (TTM, derived)
— · no payout in the trailing year
Full dividend history
Buyback program · as of Sep 30, 2026
Authorized
$1.00B
Spent (derived)
$788.00M
Remaining
$212.00M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1688568 CUSIP 23355L106 13F (30d) 451 filings 402 filers Visit website Investor relations